255 related articles for article (PubMed ID: 31932454)
1. Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.
Asem M; Young AM; Oyama C; Claure De La Zerda A; Liu Y; Yang J; Hilliard TS; Johnson J; Harper EI; Guldner I; Zhang S; Page-Mayberry T; Kaliney WJ; Stack MS
Cancer Res; 2020 Mar; 80(5):1156-1170. PubMed ID: 31932454
[TBL] [Abstract][Full Text] [Related]
2. Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells.
Carroll MJ; Fogg KC; Patel HA; Krause HB; Mancha AS; Patankar MS; Weisman PS; Barroilhet L; Kreeger PK
Cancer Res; 2018 Jul; 78(13):3560-3573. PubMed ID: 29739756
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a: A promising therapeutic target in ovarian cancer.
Zhou W; Mei J; Gu D; Xu J; Wang R; Wang H; Liu C
Pathol Res Pract; 2021 Mar; 219():153348. PubMed ID: 33540373
[TBL] [Abstract][Full Text] [Related]
4. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
[TBL] [Abstract][Full Text] [Related]
5. ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer.
Grither WR; Baker B; Morikis VA; Ilagan MXG; Fuh KC; Longmore GD
Mol Cancer Res; 2024 May; 22(5):495-507. PubMed ID: 38334461
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer.
Qi H; Sun B; Zhao X; Du J; Gu Q; Liu Y; Cheng R; Dong X
Oncol Rep; 2014 Aug; 32(2):771-9. PubMed ID: 24898696
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1.
Wang C; Wang J; Shen X; Li M; Yue Y; Cheng X; Lu W; Wang X; Xie X
J Exp Clin Cancer Res; 2021 Mar; 40(1):101. PubMed ID: 33726799
[TBL] [Abstract][Full Text] [Related]
8. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
[TBL] [Abstract][Full Text] [Related]
10. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
[TBL] [Abstract][Full Text] [Related]
11. Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment.
Hilliard TS; Kowalski B; Iwamoto K; Agadi EA; Liu Y; Yang J; Asem M; Klymenko Y; Johnson J; Shi Z; Marfowaa G; Yemc MG; Petrasko P; Stack MS
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830322
[TBL] [Abstract][Full Text] [Related]
12. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
[TBL] [Abstract][Full Text] [Related]
13. LGR4 maintains HGSOC cell epithelial phenotype and stem-like traits.
Wang Z; Yin P; Sun Y; Na L; Gao J; Wang W; Zhao C
Gynecol Oncol; 2020 Dec; 159(3):839-849. PubMed ID: 32980127
[TBL] [Abstract][Full Text] [Related]
14. Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation.
Dehghani-Ghobadi Z; Sheikh Hasani S; Arefian E; Hossein G
Cells; 2022 Jan; 11(2):. PubMed ID: 35053353
[TBL] [Abstract][Full Text] [Related]
15. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
16. Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer.
Pascual-Antón L; Cardeñes B; Sainz de la Cuesta R; González-Cortijo L; López-Cabrera M; Cabañas C; Sandoval P
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768926
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination.
Klymenko Y; Bos B; Campbell L; Loughran E; Liu Y; Yang J; Kim O; Stack MS
Sci Rep; 2020 Jul; 10(1):10877. PubMed ID: 32616784
[TBL] [Abstract][Full Text] [Related]
19. 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer.
Peng J; Yang X; Li X; Gao H; Liu N; Guo X
Cell Cycle; 2019 Aug; 18(16):1925-1937. PubMed ID: 31290719
[TBL] [Abstract][Full Text] [Related]
20. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer.
Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V
Gynecol Oncol; 2014 Aug; 134(2):338-45. PubMed ID: 24924122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
